Tremor Monitoring and Severity Quantification Systems for Parkinson's Disease and Movement Disorders: A Literature Review

Tremor monitoring for Parkinson's disease and related movement disorders has progressed from early accelerometer-based classification studies to a diverse ecosystem of inertial, electromyographic, smartphone, visionbased, and embedded IoT systems, several of which now report classification accuracies above 90% for tremor detection and above 95% for severity grading under laboratory conditions. The literature reviewed here shows consistent evidence that combining complementary sensing modalities, and combining time-domain, frequency-domain, and statistical features, improves performance relative to any single modality or feature domain in isolation. At the same time, small and imbalanced datasets, inconsistent methodology, and a near-total absence of external validation remain the field's most persistent limitations, and these limitations, rather than any deficiency in the underlying sensing or modeling techniques, are what currently separate laboratory-validated tremor-quantification algorithms from dependable clinical tools. Embedded systems built around low-cost microcontrollers and inertial sensors have already demonstrated frequency-measurement accuracy comparable to commercial smartwatches. The hardware barrier to continuous, real-world tremor monitoring therefore appears lower than the methodological one. Closing that methodological gap, through larger and better-validated datasets, standardized protocols, and interpretable, power aware models, is the clearest path from the body of work reviewed in this paper to tools that clinicians and patients can actually use.  

[1]     R. B. Postuma, D. Berg, M. Stern, W. Poewe, C. W. Olanow, W. Oertel, J. Obeso, K. Marek, I. Litvan, A. E. Lang et al., ``MDS clinical diagnostic criteria for Parkinson's disease,'' Movement Disorders, vol. 30, no. 12, pp. 1591–1601, 2015. [2]  P. J. Garcia Ruiz, M. J. Catalan, and J. M. Fernández Carril,``Initial motor symptoms of Parkinson disease,'' The Neurologist, vol. 17, pp. S18–S20, 2011. [3]   D. Muslimović, B. Post, J. D. Speelman, B. Schmand, R. J. de Haan et al., ``Determinants of disability and quality of life in mild to moderate Parkinson disease,'' Neurology, vol. 70, no. 23, pp. 2241–2247, 2008. [4]    C. G. Goetz, W. Poewe, O. Rascol, C. Sampaio, G. T. Stebbins, C. Counsell, N. Giladi, R. G. Holloway, C. G. Moore,G. K. Wenning et al., ``Movement Disorder Society task force report on the Hoehn and Yahr staging scale: status and recommendations,'' Movement Disorders, vol. 19, no. 9, pp. 1020–1028, 2004. [5]   C. G. Goetz, B. C. Tilley, S. R. Shaftman, G. T. Stebbins, S. Fahn, P. Martinez-Martin, W. Poewe, C. Sampaio, M. B. Stern, R. Dodel et al., ``Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results,'' Movement Disorders, vol. 23, no. 15, pp. 2129–2170, 2008. [6]  E. Rovini, C. Maremmani, and F. Cavallo, ``How wearable sensors can support Parkinson's disease diagnosis and treatment: a systematic review,'' Frontiers in Neuroscience, vol. 11, p. 555, 2017. [7]    M. Sica, S. Tedesco, C. Crowe, L. Kenny, K. Moore, S. Timmons,  J.  Barton,  B.  O'Flynn,  and  D.-S.  Komaris,``Continuous home monitoring of Parkinson's disease using inertial sensors: a systematic review,'' PLoS ONE, vol. 16, no. 2, p. e0246528, 2021. [8]   S. Ancona, F. D. Faraci, E. Khatab, L. Fiorillo, O. Gnarra,T. Nef, C. L. A. Bassetti, and P. Bargiotas, ``Wearables in the home-based assessment of abnormal movements in Parkinson's disease: a systematic review of the literature,'' Journal of Neurology, vol. 269, no. 1, pp. 100–110, 2022. [9]    M. F. Dirkx and M. Bologna, ``The pathophysiology of Parkinson's disease tremor,'' Journal of the Neurological Sciences, vol. 435, p. 120196, 2022. [10]  T. A. Saifee, ``Tremor,'' British Medical Bulletin, vol. 130, no. 1, pp. 51–63, 2019.